|
1
|
Gallogly MM and Lazarus HM: Midostaurin:
An emerging treatment for acute myeloid leukemia patients. J Blood
Med. 7:73–83. 2016.PubMed/NCBI
|
|
2
|
Grain A, Sirvent A, Strullu M, Françoise
M, Mohty M, Guillaume T, Chevallier P and Rialland F: Sustained
responses after clofarabine-based sequential allogeneic stem cell
transplantation in children with high-risk, relapse and/or
refractory acute myeloid leukemia or juvenile myelomonocytic
leukemia: A study on behalf of the French society of bone marrow
transplantation or cell therapy (SFGM-TC). Leuk Lymphoma.
57:2937–2941. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yung KW, Yung TT, Chung CY, Tong GT, Liu
Y, Henderson J, Welbeck D and Oseni S: Principles of cancer
staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
4
|
Sterling B, Cole R, Jen KK and Shieh JS:
Surgical oncology in the elderly. Asian Pac J Surg Oncol. 1:83–100.
2015.
|
|
5
|
Lee R, Yeung AW, Hong SE, Brose MS and
Michels DL: Principles of medical oncology. Asian Pac J Surg Oncol.
1:39–46. 2015.
|
|
6
|
Buchanan J and Tirado CA: A
t(16;21)(p11;q22) in acute myeloid leukemia (AML) resulting in
fusion of the FUS/TLS and ERG genes: A review of the literature. J
Assoc Genet Technol. 42:24–33. 2016.PubMed/NCBI
|
|
7
|
Presta M, Dell'Era P, Mitola S, Moroni E,
Ronca R and Rusnati M: Fibroblast growth factor/fibroblast growth
factor receptor system in angiogenesis. Cytokine Growth Factor Rev.
16:159–178. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hajime M, Shuichi Y, Makoto N, Masanori Y,
Ikuko K, Atsushi K, Mutsuo S and Keiichi T: Inhibitory effect of
4-methylesculetin on hyaluronan synthesis slows the development of
human pancreatic cancer in vitro and in nude mice. Int J Cancer.
120:2704–2709. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Bont ES, Rosati S, Jacobs S, Kamps WA
and Vellenga E: Increased bone marrow vascularization in patients
with acute myeloid leukaemia: A possible role for vascular
endothelial growth factor. Br J Haematol. 113:296–304. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Milella M, Falcone I, Conciatori F, Cesta
Incani U, Del Curatolo A, Inzerilli N, Nuzzo CM, Vaccaro V, Vari S,
Cognetti F and Ciuffreda L: PTEN: Multiple functions in human
malignant tumors. Front Oncol. 5:242015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hopkins BD, Hodakoski C, Barrows D, Mense
SM and Parsons RE: PTEN function: The long and the short of it.
Trends Biochem Sci. 39:183–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yonemura Y, Endou Y, Fujita H, Fushida S,
Bandou E, Taniguchi K, Miwa K, Sugiyama K and Sasaki T: Role of
MMP-7 in the formation of peritoneal dissemination in gastric
cancer. Gastric Cancer. 3:63–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kioi M, Yamamoto K, Higashi S, Koshikawa
N, Fujita K and Miyazaki K: Matrilysin (MMP-7) induces homotypic
adhesion of human colon cancer cells and enhances their metastatic
potential in nude mouse model. Oncogene. 22:8662–8670. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Safranek J, Pesta M, Holubec L, Kulda V,
Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J and Treska
V: Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung
tissue of patients with non-small cell lung cancer (NSCLC) and
benign pulmonary disease. Anticancer Res. 29:2513–2517.
2009.PubMed/NCBI
|
|
15
|
Chang MC, Chen CA, Chen PJ, Chiang YC,
Chen YL, Mao TL, Lin HW, Lin Chiang WH and Cheng WF: Mesothelin
enhances invasion of ovarian cancer by inducing MMP-7 through
MAPK/ERK and JNK pathways. Biochem J. 442:293–302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koskensalo S, Mrena J, Wiksten JP,
Nordling S, Kokkola A, Hagström J and Haglund C: MMP-7
overexpression is an independent prognostic marker in gastric
cancer. Tumour Biol. 31:149–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mitsiades N, Yu WH, Poulaki V, Tsokos M
and Stamenkovic I: Matrix metalloproteinase-7-mediated cleavage of
Fas ligand protects tumor cells from chemotherapeutic drug
cytotoxicity. Cancer Res. 61:577–581. 2001.PubMed/NCBI
|
|
18
|
Sanna M, Caocci G, Vacca A, Piras E, Orrù
F and La Nasa G: Daunorubicin, cytarabine, and cladribine regimen
plus radiotherapy and donor lymphocyte infusion for extramedullary
relapse of acute myeloid leukemia after hematopoietic stem cell
transplantation. Case Rep Hematol. 2013:2580282013.PubMed/NCBI
|
|
19
|
Folkman J and Hochberg M: Self-regulation
of growth in three dimensions. J Exp Med. 138:745–753. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Poon RT, Fan ST and Wong J: Clinical
implications of circulating angiogenic factors in cancer patients.
J Clin Oncol. 19:1207–1225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones LW, Fels DR, West M, Allen JD,
Broadwater G, Barry WT, Wilke LG, Masko E, Douglas PS, Dash RC, et
al: Modulation of circulating angiogenic factors and tumor biology
by aerobic training in breast cancer patients receiving neoadjuvant
chemotherapy. Cancer Prev Res (Phila). 6:925–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hussong JW, Rodgers GM and Shami PJ:
Evidence of increased angiogenesis in patients with acute myeloid
leukemia. Blood. 95:309–313. 2000.PubMed/NCBI
|
|
23
|
Mineo M, Garfield SH, Taverna S, Flugy A,
De Leo G, Alessandro R and Kohn EC: Exosomes released by K562
chronic myeloid leukemia cells promote angiogenesis in a
Src-dependent fashion. Angiogenesis. 15:33–45. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McKee C, Perez-Cruet M, Chavez F and
Chaudhry GR: Simplified three-dimensional culture system for
long-term expansion of embryonic stem cells. World J Stem Cells.
7:1064–1077. 2015.PubMed/NCBI
|
|
25
|
Bieker R, Padró T, Kramer J, Steins M,
Kessler T, Retzlaff S, Herrera F, Kienast J, Berdel WE and Mesters
RM: Overexpression of basic fibroblast growth factor and autocrine
stimulation in acute myeloid leukemia. Cancer Res. 63:7241–7246.
2003.PubMed/NCBI
|
|
26
|
Cheng HW, Li CW, Chan KY, Au HY, Chan PF,
Sin YC, Szeto Y and Sham MK: End-of-life characteristics and
palliative care provision for elderly patients suffering from acute
myeloid leukemia. Support Care Cancer. 23:111–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Burgucu D, Guney K, Sahinturk D, Ozbudak
IH, Ozel D, Ozbilim G and Yavuzer U: Tbx3 represses PTEN and is
over-expressed in head and neck squamous cell carcinoma. BMC
Cancer. 12:4812012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li L, Wang LX, Xu GL, Yang F, Gao QL, Niu
H, Shi B and Jiang X: Bio-informatics analysis of renal carcinoma
gene matrix metalloproteinase-7. Indian J Cancer. 53:13–18. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mieszało K, Ławicki S and Szmitkowski M:
The utility of metalloproteinases (MMPs) and their inhibitors
(TIMPs) in diagnostics of gynecological malignancies. Pol Merkur
Lekarski. 40:193–197. 2016.(In Polish). PubMed/NCBI
|
